Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion (updated)

Deciphera Pharmaceuticals

29/04/2024 12:18

(Adds details on deal in paragraph 2)
       April 29 (Reuters) - Deciphera Pharmaceuticals  DCPH.O 
said on Monday Japan's Ono Pharmaceutical Co  4528.T  will
acquire the cancer drug developer for $2.4 billion in cash.
    Ono Pharma has offered $25.60 per share, a premium of 74.7%
to the U.S. company's last closing price of $14.65. 
    Premarket trading of Deciphera's shares was currently
halted.
    The acquisition is expected to close in the third quarter of
2024, Deciphera said.
    

 (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini
Ganguli)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))